Consistently, we found that the correlation value of a positive relationship between CISD2 expression and CD8+ T cells was significantly decreased with glioma progression in TIMER, indicating that CISD2 might exert an inhibitory effect on CD8+ T cells with tumor progression. Here, CISD2 is linked to central nervous system cancer.